135 related articles for article (PubMed ID: 10852317)
1. No effect of low-dose aspirin for the prevention of heterotopic bone formation after total hip replacement: a randomized trial of 2,649 patients.
Neal BC; Rodgers A; Gray H; Clark T; Beaumont DD; House T; Douglas JE; Reid IR; MacMahon SW
Acta Orthop Scand; 2000 Apr; 71(2):129-34. PubMed ID: 10852317
[TBL] [Abstract][Full Text] [Related]
2. A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery.
Neal BC; Rodgers A; Clark T; Gray H; Reid IR; Dunn L; MacMahon SW
Acta Orthop Scand; 2000 Apr; 71(2):122-8. PubMed ID: 10852316
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): randomised controlled trial.
Fransen M; Anderson C; Douglas J; MacMahon S; Neal B; Norton R; Woodward M; Cameron ID; Crawford R; Lo SK; Tregonning G; Windolf M;
BMJ; 2006 Sep; 333(7567):519. PubMed ID: 16885182
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty.
Neal B; Rodgers A; Dunn L; Fransen M
Cochrane Database Syst Rev; 2000; (3):CD001160. PubMed ID: 10908488
[TBL] [Abstract][Full Text] [Related]
5. Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty.
Fransen M; Neal B
Cochrane Database Syst Rev; 2004; (3):CD001160. PubMed ID: 15266441
[TBL] [Abstract][Full Text] [Related]
6. Preventing chronic ectopic bone-related pain and disability after hip replacement surgery with perioperative ibuprofen. A multicenter, randomized, double-blind, placebo-controlled trial (HIPAID).
Fransen M;
Control Clin Trials; 2004 Apr; 25(2):223-33. PubMed ID: 15020038
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Heterotopic Ossification Following a Multimodal Pain Protocol in Total Hip Arthroplasty With the Posterior Approach.
White PB; Ramkumar PN; Meftah M; Ghazi N; Ranawat AS; Ranawat CS
Orthopedics; 2018 Jan; 41(1):e92-e97. PubMed ID: 29120007
[TBL] [Abstract][Full Text] [Related]
8. WITHDRAWN: Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty.
Fransen M; Neal B
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD001160. PubMed ID: 23543510
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of heterotopic ossification in cemented versus noncemented total hip joint replacement in patients with osteoarthrosis: a randomized clinical trial.
Nayak KN; Mulliken B; Rorabeck CH; Bourne RB; Woolfrey MR
Can J Surg; 1997 Oct; 40(5):368-74. PubMed ID: 9336527
[TBL] [Abstract][Full Text] [Related]
10. Heterotopic ossification is less after THA in patients who receive aspirin compared to coumadin.
Cohn RM; Della Valle AG; Cornell CN
Bull NYU Hosp Jt Dis; 2010; 68(4):266-72. PubMed ID: 21162704
[TBL] [Abstract][Full Text] [Related]
11. Heterotopic ossification in patients after total hip replacement.
Stołtny T; Koczy B; Wawrzynek W; Miszczyk L
Ortop Traumatol Rehabil; 2007; 9(3):264-72. PubMed ID: 17721424
[TBL] [Abstract][Full Text] [Related]
12. Aspirin decreases the prevalence and severity of heterotopic ossification after 1-stage bilateral total hip arthroplasty for osteoarthrosis.
Bek D; Beksaç B; Della Valle AG; Sculco TP; Salvati EA
J Arthroplasty; 2009 Feb; 24(2):226-32. PubMed ID: 18534420
[TBL] [Abstract][Full Text] [Related]
13. Prevention of heterotopic ossification with tenoxicam following total hip arthroplasty: a double-blind, placebo-controlled dose-finding study.
Burssens A; Thiery J; Kohl P; Molderez A; Haazen L
Acta Orthop Belg; 1995; 61(3):205-11. PubMed ID: 8525817
[TBL] [Abstract][Full Text] [Related]
14. Indomethacin for prevention of heterotopic ossification after hip arthroplasty. A randomized comparison between 4 and 8 days of treatment.
Dorn U; Grethen C; Effenberger H; Berka H; Ramsauer T; Drekonja T
Acta Orthop Scand; 1998 Apr; 69(2):107-10. PubMed ID: 9602763
[TBL] [Abstract][Full Text] [Related]
15. General short-term indomethacin prophylaxis to prevent heterotopic ossification in total hip arthroplasty.
Hofmann S; Trnka HJ; Metzenroth H; Frank E; Ritschl P; Salzer M
Orthopedics; 1999 Feb; 22(2):207-11. PubMed ID: 10037334
[TBL] [Abstract][Full Text] [Related]
16. Celecoxib and heterotopic bone formation after total hip arthroplasty.
Lavernia CJ; Contreras JS; Villa JM; Rossi MD
J Arthroplasty; 2014 Feb; 29(2):390-2. PubMed ID: 23927909
[TBL] [Abstract][Full Text] [Related]
17. Do non-steroidal anti-inflammatory drugs cause endoprosthetic loosening? A 10-year follow-up of a randomized trial on ibuprofen for prevention of heterotopic ossification after hip arthroplasty.
Persson PE; Nilsson OS; Berggren AM
Acta Orthop; 2005 Dec; 76(6):735-40. PubMed ID: 16470423
[TBL] [Abstract][Full Text] [Related]
18. Ketorolac prophylaxis against heterotopic ossification after hip replacement.
Pritchett JW
Clin Orthop Relat Res; 1995 May; (314):162-5. PubMed ID: 7634630
[TBL] [Abstract][Full Text] [Related]
19. Prevention of periarticular heterotopic ossification after endoprosthetic hip joint replacement by means of diclofenac.
Jockheck M; Willms R; Volkmann R; Sell S; Weller S; Küsswetter W
Arch Orthop Trauma Surg; 1998; 117(6-7):337-40. PubMed ID: 9709846
[TBL] [Abstract][Full Text] [Related]
20. Heterotopic bone formation in total hip arthroplasty: predisposing factors, classification and the significance for clinical outcome.
Schara K; Herman S
Acta Chir Orthop Traumatol Cech; 2001; 68(2):105-8. PubMed ID: 11706718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
